TCL Archive Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors October 31, 2014
TCL Archive The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power October 31, 2014
TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive In Brief: Deadline June 1 For Cancer Research Institute Grants; Chabner To Present Karnofsky Lecture May 3, 1985
